News tagged with androgen deprivation

Study identifies a key cellular pathway in prostate cancer

Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor—the cellular component ...

Feb 10, 2014
popularity 5 / 5 (2) | comments 0 | with audio podcast

Abiraterone: Hint of considerable added benefit

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms ...

Jul 02, 2013
popularity not rated yet | comments 0